Stephan Hjorth

CVMD Innovative Medicines, AstraZeneca R&D
Moelndal, O, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

Cariprazine and clozapine: a systematic review of a promising antipsychotic combination for treatment-resistant schizophrenia.

Cariprazine and clozapine: a systematic review of a promising antipsychotic combination for treatment-resistant schizophrenia.

Journal: The international journal of neuropsychopharmacology

Published: May 12, 2025

Neurophysiological treatment effects of mesdopetam, pimavanserin and clozapine in a rodent model of Parkinson's disease psychosis.

Neurophysiological treatment effects of mesdopetam, pimavanserin and clozapine in a rodent model of Parkinson's disease psychosis.

Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics

Published: December 08, 2023

Long-term incidence of haematological cancer after bariatric surgery or usual care in the Swedish Obese Subjects study: a prospective cohort study.

Long-term incidence of haematological cancer after bariatric surgery or usual care in the Swedish Obese Subjects study: a prospective cohort study.

Journal: The lancet. Healthy longevity

Published: March 21, 2023

Successful switching from risperidone to cariprazine in a schizophrenic patient with pronounced functional deficit. Case report.

Successful switching from risperidone to cariprazine in a schizophrenic patient with pronounced functional deficit. Case report.

Journal: Frontiers in psychiatry

Published: January 31, 2023

Remission of Persistent Negative Symptoms and Psychosocial Consequences by Combined Clozapine and Cariprazine Treatment in a Patient With Long-Standing Treatment-Resistant Schizoaffective Disorder.

Remission of Persistent Negative Symptoms and Psychosocial Consequences by Combined Clozapine and Cariprazine Treatment in a Patient With Long-Standing Treatment-Resistant Schizoaffective Disorder.

Journal: Frontiers in psychiatry

Published: March 01, 2022

Turn On, Tune In, Turnover! Target Biology Impacts In Vivo Potency, Efficacy, and Clearance.

Turn On, Tune In, Turnover! Target Biology Impacts In Vivo Potency, Efficacy, and Clearance.

Journal: Pharmacological reviews

Published: October 31, 2021

The More, the Merrier…? Antipsychotic Polypharmacy Treatment Strategies in Schizophrenia From a Pharmacology Perspective.

The More, the Merrier…? Antipsychotic Polypharmacy Treatment Strategies in Schizophrenia From a Pharmacology Perspective.

Journal: Frontiers in psychiatry

Published: August 17, 2021

Case Report: Cariprazine in a Patient With Schizophrenia, Substance Abuse, and Cognitive Dysfunction.

Case Report: Cariprazine in a Patient With Schizophrenia, Substance Abuse, and Cognitive Dysfunction.

Journal: Frontiers in psychiatry

Published: June 19, 2021

(3S)-3-(2,3-difluorophenyl)-3-methoxypyrrolidine (IRL752) -a Novel Cortical-Preferring Catecholamine Transmission- and Cognition-Promoting Agent.

(3S)-3-(2,3-difluorophenyl)-3-methoxypyrrolidine (IRL752) -a Novel Cortical-Preferring Catecholamine Transmission- and Cognition-Promoting Agent.

Journal: The Journal of pharmacology and experimental therapeutics

Published: April 02, 2020

Preclinical Pharmacology of [2-(3-Fluoro-5-Methanesulfonyl-phenoxy)Ethyl](Propyl)amine (IRL790), a Novel Dopamine Transmission Modulator for the Treatment of Motor and Psychiatric Complications in Parkinson Disease.

Preclinical Pharmacology of [2-(3-Fluoro-5-Methanesulfonyl-phenoxy)Ethyl](Propyl)amine (IRL790), a Novel Dopamine Transmission Modulator for the Treatment of Motor and Psychiatric Complications in Parkinson Disease.

Journal: The Journal of pharmacology and experimental therapeutics

Published: December 18, 2019

Does In Vitro Potency Predict Clinically Efficacious Concentrations?

Does In Vitro Potency Predict Clinically Efficacious Concentrations?

Journal: Clinical pharmacology and therapeutics

Published: October 09, 2019

Revisions of Gastric Bypass-A Moral Obligation-Reply.

Revisions of Gastric Bypass-A Moral Obligation-Reply.

Journal: JAMA surgery

Published: June 20, 2019

Showing 1-12 of 28

Last Updated: 09/26/2026